CytomX Therapeutics, Inc. financial data

Symbol
CTMX on Nasdaq
Industry
Pharmaceutical Preparations
Location
151 Oyster Point Blvd., Suite 400, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 110 % -22.5%
Debt-to-equity -612 % -52.9%
Return On Equity -41.3 % -413%
Return On Assets 8.08 %
Operating Margin 5.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.3M shares +16.8%
Common Stock, Shares, Outstanding 67.3M shares +1.64%
Entity Public Float 114M USD -3.63%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 85.1M shares +5.4%
Weighted Average Number of Shares Outstanding, Diluted 85.2M shares +5.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 127M USD +33.7%
Revenue from Contract with Customer, Excluding Assessed Tax 127M USD +33.7%
Research and Development Expense 88M USD +13%
General and Administrative Expense 31.9M USD -1.02%
Operating Income (Loss) 6.71M USD +31.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 15.1M USD -0.31%
Income Tax Expense (Benefit) 1.23M USD -56.4%
Net Income (Loss) Attributable to Parent 13.8M USD +91.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 40.6M USD +55.9%
Cash, Cash Equivalents, and Short-term Investments 119M USD -39.3%
Accounts Receivable, after Allowance for Credit Loss, Current 3.35M USD +38.6%
Assets, Current 124M USD -38.3%
Property, Plant and Equipment, Net 2.94M USD -27.5%
Operating Lease, Right-of-Use Asset 9.19M USD -30.3%
Goodwill 949K USD 0%
Other Assets, Noncurrent 70K USD -19.5%
Assets 139M USD -37.2%
Accounts Payable, Current 1.42M USD -16.6%
Employee-related Liabilities, Current 7.41M USD +4.41%
Accrued Liabilities, Current 16.7M USD -19.1%
Contract with Customer, Liability, Current 96.1M USD -22.8%
Liabilities, Current 119M USD -18.8%
Contract with Customer, Liability, Noncurrent 33.6M USD -70.1%
Operating Lease, Liability, Noncurrent 5.6M USD -47.2%
Other Liabilities, Noncurrent 4.05M USD +47%
Liabilities 162M USD -40.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 40K USD
Retained Earnings (Accumulated Deficit) -710M USD +1.91%
Stockholders' Equity Attributable to Parent -23.5M USD +54.2%
Liabilities and Equity 139M USD -37.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -26M USD -379%
Net Cash Provided by (Used in) Financing Activities 174K USD
Net Cash Provided by (Used in) Investing Activities 44.9M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 67.3M shares +1.64%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 175M USD +5.67%
Deferred Tax Assets, Gross 179M USD +5.41%
Operating Lease, Liability 14M USD -22.6%
Payments to Acquire Property, Plant, and Equipment 115K USD +140%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 13.9M USD +99.7%
Lessee, Operating Lease, Liability, to be Paid 15.7M USD -25.7%
Property, Plant and Equipment, Gross 18.6M USD -4.11%
Operating Lease, Liability, Current 5M USD +12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.73M USD +2.82%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.57M USD +2.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.71M USD -43.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.39M USD -23.4%
Deferred Tax Assets, Operating Loss Carryforwards 56.8M USD -2.45%
Unrecognized Tax Benefits 19.4M USD +109%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.39M USD -23.4%
Additional Paid in Capital 687M USD +2.06%
Amortization of Intangible Assets 36K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 3.36M USD -6.57%
Share-based Payment Arrangement, Expense 14.6M USD +6.19%